| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |